Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far?

Table 1

Mean survival time and disease-specific mortality by therapeutic modality, adapted from Antwi and Everson (2014) [4].

Therapeutic modality	Average survival time after diagnosis (months)	DSM (%)
RP	29	15,3
BT	31	28,3
NLT	17	45,4

DSM: disease-specific mortality; RP: radical prostatectomy; BT: brachytherapy; NLT: no local treatment.